Helen Lillistone
Corporate Officer/Principal bei VELOCYS
Profil
Helen Alice Lillistone is currently the Director at Shire Holdings Europe Ltd., Director at NPS Pharma UK Ltd., and Head-Global Finance & Information Technology at Velocys Plc.
Previously, she worked as a Director at Viropharma Ltd.
and Head-European Finance Operations at Shire Plc.
She completed her undergraduate degree at Southampton Business School.
Aktive Positionen von Helen Lillistone
| Unternehmen | Position | Beginn |
|---|---|---|
| VELOCYS | Corporate Officer/Principal | - |
Shire Holdings Europe Ltd.
 Shire Holdings Europe Ltd. Financial ConglomeratesFinance Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The private company is based in London, UK. | Director/Board Member | 24.03.2016 |
NPS Pharma UK Ltd.
 NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., NPS Pharma UK Ltd. is a private company that develops and markets medicines for patients with rare diseases. The company is based in London, UK and was founded in 2006. | Director/Board Member | 24.03.2016 |
Ehemalige bekannte Positionen von Helen Lillistone
| Unternehmen | Position | Ende |
|---|---|---|
Viropharma Ltd.
 Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | 31.12.2018 |
| SHIRE | Corporate Officer/Principal | - |
Ausbildung von Helen Lillistone
| Southampton Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VELOCYS | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Holdings Europe Ltd.
Shire Holdings Europe Ltd. Financial ConglomeratesFinance Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The private company is based in London, UK. | Finance |
Viropharma Ltd.
Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
NPS Pharma UK Ltd.
NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., NPS Pharma UK Ltd. is a private company that develops and markets medicines for patients with rare diseases. The company is based in London, UK and was founded in 2006. | Health Technology |
